CIRCLE DESIGN

Trademark usage description

pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, Read More

Vienna Information

26 . 15 . 1

SpheresSphères

1 . 15 . 9

Luminous sources, rays, shafts of lightSources lumineuses, rayons, faisceaux de lumière

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 13

Circles or ellipses containing representations of heavenly bodies or natural phenomenaCercles ou ellipses contenant la représentation de corps célestes ou de phénomènes naturels

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 7 . 3

Circles or ellipses with one or more triangles and/or lines forming an angleCercles ou ellipses avec un ou plusieurs triangles et/ou lignes formant un angle

25 . 1 . 6

Banderoles, cartouchesBanderoles, cartouches

26 . 3 . 4

Several triangles, juxtaposed, joined or intersectingPlusieurs triangles, juxtaposés, accolés ou se coupant

26 . 3 . 6

Triangular figures with one or more convex or concave sidesFigures triangulaires à un ou plusieurs côtés convexes ou concaves

26 . 3 . 7

Triangular figures with one or more truncated or rounded anglesFigures triangulaires à un ou plusieurs angles coupés ou arrondis

26 . 3 . 24

Triangles with dark surfaces or parts of surfacesTriangles avec surface ou partie de la surface foncée

Classification Information

Class [005]
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, antibacterials, antivirals, antibiotics, systemic and topical antifungals.

Classification kind code

Mark Details

Serial Number

2089066

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 4^th Jul 2022	Search Recorded
Submitted for opposition 20 on 4^th Jul 2022	Examiner's First Report
Submitted for opposition 223 on 4^th Jul 2022	Total Provisional Refusal
Submitted for opposition 256 on 4^th Jan 2022	Notification of Possible Opposition Sent
Submitted for opposition 257 on 4^th Mar 2021	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 3^rd Mar 2021	Created
Submitted for opposition 31 on 3^rd Mar 2021	Formalized
Submitted for opposition 30 on 30^th Dec 2020	Filed
Submitted for opposition 238 on 13^th Apr 2015	IR Renewed
Submitted for opposition 228 on 13^th Apr 2005	International Registration